These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29596844)

  • 1. Molecular pathology of Multiple Sclerosis lesions reveals a heterogeneous expression pattern of genes involved in oligodendrogliogenesis.
    Zeis T; Howell OW; Reynolds R; Schaeren-Wiemers N
    Exp Neurol; 2018 Jul; 305():76-88. PubMed ID: 29596844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination.
    Mohan H; Friese A; Albrecht S; Krumbholz M; Elliott CL; Arthur A; Menon R; Farina C; Junker A; Stadelmann C; Barnett SC; Huitinga I; Wekerle H; Hohlfeld R; Lassmann H; Kuhlmann T; Linington C; Meinl E
    Acta Neuropathol Commun; 2014 Dec; 2():168. PubMed ID: 25589163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection.
    Zeis T; Graumann U; Reynolds R; Schaeren-Wiemers N
    Brain; 2008 Jan; 131(Pt 1):288-303. PubMed ID: 18056737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions.
    Mews I; Bergmann M; Bunkowski S; Gullotta F; Brück W
    Mult Scler; 1998 Apr; 4(2):55-62. PubMed ID: 9599334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelination in Multiple Sclerosis Lesions Is Associated with Regulation of Bone Morphogenetic Protein 4 and Its Antagonist Noggin.
    Harnisch K; Teuber-Hanselmann S; Macha N; Mairinger F; Fritsche L; Soub D; Meinl E; Junker A
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions.
    Fransen NL; Hsiao CC; van der Poel M; Engelenburg HJ; Verdaasdonk K; Vincenten MCJ; Remmerswaal EBM; Kuhlmann T; Mason MRJ; Hamann J; Smolders J; Huitinga I
    Brain; 2020 Jun; 143(6):1714-1730. PubMed ID: 32400866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-scale MRI spectrum detects differences in myelin integrity between MS lesion types.
    Zhang Y; Jonkman L; Klauser A; Barkhof F; Yong VW; Metz LM; Geurts JJ
    Mult Scler; 2016 Oct; 22(12):1569-1577. PubMed ID: 26754802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter.
    Melief J; de Wit SJ; van Eden CG; Teunissen C; Hamann J; Uitdehaag BM; Swaab D; Huitinga I
    Acta Neuropathol; 2013 Aug; 126(2):237-49. PubMed ID: 23812288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin regulatory factor drives remyelination in multiple sclerosis.
    Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
    Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of glucose-metabolizing enzymes in multiple sclerosis lesions.
    Nijland PG; Molenaar RJ; van der Pol SM; van der Valk P; van Noorden CJ; de Vries HE; van Horssen J
    Acta Neuropathol Commun; 2015 Dec; 3():79. PubMed ID: 26637184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms.
    Fransen NL; Crusius JBA; Smolders J; Mizee MR; van Eden CG; Luchetti S; Remmerswaal EBM; Hamann J; Mason MRJ; Huitinga I
    Brain Pathol; 2020 Jan; 30(1):106-119. PubMed ID: 31228212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique RNA signature of different lesion types in the brain white matter in progressive multiple sclerosis.
    Elkjaer ML; Frisch T; Reynolds R; Kacprowski T; Burton M; Kruse TA; Thomassen M; Baumbach J; Illes Z
    Acta Neuropathol Commun; 2019 Apr; 7(1):58. PubMed ID: 31023379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular signature of different lesion types in the brain white matter of patients with progressive multiple sclerosis.
    Elkjaer ML; Frisch T; Reynolds R; Kacprowski T; Burton M; Kruse TA; Thomassen M; Baumbach J; Illes Z
    Acta Neuropathol Commun; 2019 Dec; 7(1):205. PubMed ID: 31829262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional profiling of microdissected areas of active multiple sclerosis lesions reveals activation of heat shock protein genes.
    Mycko MP; Brosnan CF; Raine CS; Fendler W; Selmaj KW
    J Neurosci Res; 2012 Oct; 90(10):1941-8. PubMed ID: 22715030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling of the astrocyte transcriptome in multiple sclerosis normal appearing white matter reveals a neuroprotective role.
    Waller R; Woodroofe MN; Wharton SB; Ince PG; Francese S; Heath PR; Cudzich-Madry A; Thomas RH; Rounding N; Sharrack B; Simpson JE
    J Neuroimmunol; 2016 Oct; 299():139-146. PubMed ID: 27725112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.
    Koning N; Bö L; Hoek RM; Huitinga I
    Ann Neurol; 2007 Nov; 62(5):504-14. PubMed ID: 17879969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance.
    Barkhof F; Bruck W; De Groot CJ; Bergers E; Hulshof S; Geurts J; Polman CH; van der Valk P
    Arch Neurol; 2003 Aug; 60(8):1073-81. PubMed ID: 12925362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis of the microvascular compartment in multiple sclerosis using laser microdissected blood vessels.
    Cunnea P; McMahon J; O'Connell E; Mashayekhi K; Fitzgerald U; McQuaid S
    Acta Neuropathol; 2010 May; 119(5):601-15. PubMed ID: 19967542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis.
    Coman I; Aigrot MS; Seilhean D; Reynolds R; Girault JA; Zalc B; Lubetzki C
    Brain; 2006 Dec; 129(Pt 12):3186-95. PubMed ID: 16766541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human endogenous retrovirus W in brain lesions: Rationale for targeted therapy in multiple sclerosis.
    van Horssen J; van der Pol S; Nijland P; Amor S; Perron H
    Mult Scler Relat Disord; 2016 Jul; 8():11-8. PubMed ID: 27456869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.